Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Cash Flow Quality Index
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Cash Flow Quality Index of 3.05x as of December 2025. Operating cash flow of $41.05 Million exceeds net income of $13.47 Million, indicating high earnings quality where cash backs reported profits. Also explore Zhengye Biotechnology Holding Limited Or assets under control for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhengye Biotechnology Holding Limited Ordinary Shares Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for Zhengye Biotechnology Holding Limited Ordinary Shares across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ZYBT tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Year-by-year earnings quality comparison for Zhengye Biotechnology Holding Limited Ordinary Shares. For live market cap and the full company financial profile, see market value of Zhengye Biotechnology Holding Limited Or.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.05x | $41.05 Million | $13.47 Million | ▼ -16.0% |
| 2024 | 3.63x | $41.05 Million | $11.31 Million | ▲ +182.5% |
| 2023 | 1.28x | $48.18 Million | $37.51 Million | ▲ +313.1% |
| 2022 | 0.31x | $17.34 Million | $55.74 Million | ▼ -54.6% |
| 2021 | 0.68x | $31.81 Million | $46.47 Million | — |